A Medical First: CAR T Therapy Sends Three Autoimmune Conditions Into Remission
Linkedln
April 29, 2026
In the evolving landscape of modern medicine, few breakthroughs have captured as much attention as CAR T-cell therapy. Originally developed as a last-resort intervention for aggressive blood cancers, this highly personalized immunotherapy is now revealing a second, potentially transformative identity: a precision tool for resetting dysfunctional immune systems. A recent clinical case from Germany, published in the journal Med, offers a compelling glimpse into that future.
See publication
Tags: Blockchain, FinTech, Marketing
Sam Altman-Backed Controversial World ID Gains Corporate Traction in the U.S
Linkedln
April 28, 2026
The digital economy is entering a structural inflection point: the erosion of trust in online identity. Deepfakes, bot-driven fraud, and synthetic media are no longer fringe concerns but operational risks for platforms that depend on authentic human interaction. Against this backdrop, a controversial but increasingly influential approach is gaining traction—biometric “proof of humanity.”
See publication
Tags: Blockchain, FinTech, Marketing
What Does Anthropic’s Claude Mythos Breach Reveal About AI Security Limits?
Linkedln
April 23, 2026
The artificial intelligence industry has entered a phase where capability is no longer the only axis of competition; control has become just as critical. That reality was underscored recently by a report from Bloomberg that Anthropic’s much-hyped model, Claude Mythos, was accessed by an unauthorized group shortly after its restricted release.
See publication
Tags: Blockchain, FinTech, Management
The 'Oslo Patient' and the Expanding Horizon of HIV Cure Research
Linkedln
April 16, 2026
The recent case of the so-called 'Oslo Patient' marks another significant milestone in the decades-long scientific effort to move HIV from a chronic, managed condition toward a definitive cure. A 63-year-old man has entered what researchers describe as likely long-term remission following a hematopoietic stem cell transplant, joining a small but growing cohort of individuals who have achieved sustained viral control without antiretroviral therapy (ART).
See publication
Tags: Blockchain, FinTech, Marketing
